Albumin induces neuroprotection against ischemic stroke by altering toll-like receptor 4 and regulatory T cells in mice

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 2, 2013, Pages 220-227

  Wang, Min ^a   Wang, Yongming ^a   He, Jing ^a   Wei, Siyu ^a   Zhang, Na ^a   Liu, Fengyong ^a   Liu, Xin ^a   Kang, Yi ^a   Yao, Xiaomei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Albumin; Interleukin 10; Middle cerebral artery occlusion; Regulatory t cell; Toll like receptor 4; Transforming growth factor beta1

Indexed keywords

ALBUMIN; INTERLEUKIN 10; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

ALBUMINS; ANIMALS; ANTIGENS, CD; BRAIN; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-10; MALE; MICE; MICE, INBRED STRAINS; NEUROPROTECTIVE AGENTS; RNA, MESSENGER; SERUM ALBUMIN; SPLEEN; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876743644     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990058     Document Type: Article

References (36)

1. Offner, H.; Subramanian, S.; Parker, S.M.; Afentoulis, M.E.; Vandenbark, A.A.; Hurn, P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab., 2006, 26(5),654-665
2. Gelderblom, M.; Leypoldt, F.; Steinbach, K.; Behrens, D.; Choe, C.U.; Siler, D.A.; Arumugam, T.V.; Orthey, E.; Gerloff, C.; Tolosa, E.; Magnus, T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke, 2009, 40(5), 1849-1857
3. Kaushal, V.; Schlichter, L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci., 2008, 28(9), 2221-2230
4. Wang, Q.; Tang, X.N.; Yenari, M.A. The inflammatory response in stroke. J. Neuroimmunol., 2007, 184(1-2), 53-68
5. Caso, J.R.; Pradillo, J.M.; Hurtado, O.; Lorenzo, P.; Moro, M.A.; Lizasoain, I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation, 2007, 115(12), 1599-1608
6. Kawai, T.; Akira, S. TLR signaling. Semin. Immunol., 2007, 19(1), 24-32
7. Liesz, A.; Hagmann, S.; Zschoche, C.; Adamek, J.; Zhou, W.; Sun, L.; Hug, A.; Zorn, M.; Dalpke, A.; Nawroth, P.; Veltkamp, R. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke, 2009, 40(8), 2849-2858
8. Liesz, A.; Suri-Payer, E.; Veltkamp, C.; Doerr, H.; Sommer, C.; Rivest, S.; Giese, T.; Veltkamp, R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med., 2009, 15(2), 192-199
9. Bajramovic, J.J. Regulation of innate immune responses in the central nervous system. CNS Neurol Disord Drug Targets., 2011, 10(1):4-24
10. Yao, X.; Miao, W.; Li, M.; Wang, M.; Ma, J.; Wang, Y.; Miao, L.; Feng, H. Protective effect of albumin on VEGF and brain edema in acute ischemia in rats. Neurosci. Lett., 2010, 472(3), 179-183
11. Jackman, K.A.; Miller, A.A.; Drummond, G.R.; Sobey, C.G. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain. Res., 2009, 1286, 215-220
12. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25(4), 402-408
13. Ooboshi, H.; Ibayashi, S.; Shichita, T.; Kumai, Y.; Takada, J.; Ago, T.; Arakawa, S.; Sugimori, H.; Kamouchi, M.; Kitazono, T.; Iida, M. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation, 2005, 111(7), 913-919
14. Smiley, S.T.; King, J.A.; Hancock, W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol., 2001, 167(5), 2887-2894
15. Termeer, C.; Benedix, F.; Sleeman, J.; Fieber, C.; Voith, U.; Ahrens, T.; Miyake, K.; Freudenberg, M.; Galanos, C.; Simon, J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med., 2002, 195(1), 99-111
16. Gao, Y.; Fang, X.; Tong, Y.; Liu, Y.; Zhang, B. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed. Pharmacother., 2009, 63(6), 442-450
17. Gao, Y.; Fang, X.; Sun, H.; Wang, Y.; Yao, L.J.; Li, J.P.; Tong, Y.; Zhang, B.; Liu, Y. Toll-like receptor 4-mediated myeloid differentiation factor 88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in hippocampal CA1 region in mice. Biol. Pharm. Bull., 2009, 32(10), 1665-1671
18. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol., 2005, 17(1), 1-14
19. Vogel, S.N.; Fitzgerald, K.A.; Fenton, M.J. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv., 2003, 3(8), 466-477
20. Jie, Dai.; Bei, Liu.; Zihai, Li. Regulatory T cells and Toll-like receptors: What is the missing link? International Immunopharmacology, 2009, 9(5), 528-533
21. Iadecola, C.; Alexander, M. Cerebral ischemia and inflammation. Curr. Opin. Neurol., 2001, 14(1), 89-94
22. He, X.M, Carter, D.C. Atomic structure and chemistry of human serum albumin. Nature, 1992, 358(6383), 209-215
23. Belayev, L.; Liu Y.; Zhao W.; Busto, R.; Ginsberg M.D. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke, 2001, 32(2), 553-560
24. Ginsberg, M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 2008, 55, 363-389
25. Dziedzic, T.; Slowik, A.; Szczudlik, A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke, 2004, 35(6), e156-e158
26. Hyakkoku, K.; Hamanaka, J.; Tsuruma, K.; Shimazawa, M.; Tanaka, H.; Uematsu, S.; Akira, S.; Inagaki, N.; Nagai, H.; Hara, H. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience, 2010, 171(1), 258-267
27. Loures, F. V.; Pina, A.; Felonato, M.; Araújo, E.F.; Leite, K.R.; Calich, V.L. Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect. Immun., 2010, 78(3), 1078-1088
28. Hua, F.; Ma, J.; Ha, T.; Xia, Y.; Kelley, J.; Williams, D.L.; Kao, R.L.; Browder, I.W.; Schweitzer, J.B.; Kalbfleisch, J.H; Li, C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol., 2007, 190(1-2), 101-111
29. Spera, P.A.; Ellison, J.A.; Feuerstein, G.Z.; Barone, F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett., 1998, 251(3), 189-192
30. Nakamura, K.; Kitani, A.; Strober, W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med., 2001, 194(5), 629-644
31. O'Connor, R.A.; Anderton, S.M. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol., 2008, 193(1-2), 1-11
32. Sakaguchi, S.; Ono, M.; Setoguchi, R.; Yagi, H.; Hori, S.; Fehervari, Z.; Shimizu, J.; Takahashi, T.; Nomura, T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev., 2006, 212, 8-27
33. Suri-Payer, E.; Fritzsching, B. Regulatory T cells in experimental autoimmune disease. Springer. Semin. Immunopathol., 2006, 28(1), 3-16
34. Tang, Q.; Bluestone, J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol., 2008, 9(3), 239-244
35. Elango, C.; Devaraj, S. N. Immunomodulatory effect of Hawthorn extract in an experimental stroke model. J. Neuroinflammation., 2010, 7, 97-110
36. Gee, J.M.; Zierath, D.; Hadwin, J.; Savos, A.; Kalil, A.; Thullbery, M.; Becker, K.J. Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp. Transl. Stroke Med., 2009, 1, 3-13.